Stig Anders Lindberg

Director/Board Member at CAMURUS AB

Net worth: 407 225 $ as of 30/05/2026

54 year

51 connections

Health Technology

Commercial Services

Finance

Profile

Stig Anders Jakob Lindberg is the founder of Cellectricon AB, which was founded in 2000.
He held the title of Chief Executive Officer & Director at Cellectricon AB. Currently, Dr. Lindberg is the Chief Executive Officer & Director at Lindberg Life-Science AB. He is also a Director at Affibody AB, Affibody Medical AB, Amic AB, Dipylon Medical AB, Bostadsrattsforeningen Astraea, Oncopeptides Incentive AB, and Oncopeptides, Inc. Additionally, he serves as an Independent Director at Camurus AB starting in 2021.
In the past, Dr. Lindberg has held positions as a Director at Heartscape Technologies, Inc., an Independent Director at Alligator Bioscience AB, and a Director at Newron Pharmaceuticals SpA. He was also a Director at SciBase Holding AB, Newron Sweden AB, Atlas Antibodies AB, Vårdapoteket i Norden AB, Scibase Intressenter AB, Fiomi Diagnostics AB, Eirus Medical AB, Atlas Therapeutics AB, Ginolis AB, SciBase AB, Kihlstroms Frimarkshandel AB, Bostadsrattsforeningen Johannes Mindre, Merrill Lynch & Co., Inc., and McKinsey & Co., Inc. Dr. Lindberg worked as an Analyst at Merrill Lynch & Co., Inc. and as a Consultant at McKinsey & Co., Inc. He also served as a Vice President at Investor Growth Capital AB from 2004 to 2011.
From 2011 to 2024, he held the position of Chief Scientific Officer at Oncopeptides AB. Dr. Lindberg has a graduate and doctorate degree from Karolinska Institutet and an undergraduate degree from the University of Stockholm.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
ONCOPEPTIDES AB 0.54%	30/12/2024	2,077,362 ( 0.54% )	407 225 $	30/05/2026

Stig Anders Lindberg active positions

Companies	Position	Start
CAMURUS AB	Director/Board Member	31/12/2020
Oncopeptides Incentive AB	Corporate Officer/Principal	-
Bostadsrattsforeningen Astraea	Director/Board Member	-
Lindberg Life-Science AB	Chief Executive Officer	-
Affibody AB Affibody AB BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that develops radioligand therapies for cancer treatment	Director/Board Member	-
Dipylon Medical AB Dipylon Medical AB Pharmaceuticals: MajorHealth Technology Engages in the research and development of pharmaceutical products and manufactures medical instruments	Director/Board Member	-
Affibody Medical AB Affibody Medical AB Pharmaceuticals: MajorHealth Technology Provides biopharmaceuticals services	Director/Board Member	-
Amic AB Amic AB Medical SpecialtiesHealth Technology Develops in vitro diagnostic technologies for use in point-of-care diagnostic tests	Director/Board Member	-
Oncopeptides, Inc. Oncopeptides, Inc. Medical/Nursing ServicesHealth Services Develops therapies for hematological diseases	Director/Board Member	-

All active positions of Stig Anders Lindberg

Former positions of Stig Anders Lindberg

Companies	Position	End
░░░░░░░░░░░░ ░░	░░░░░ ░░░░░░░░░ ░░░░░░░	░░░░░░░░░░
░░░░░░ ░░░░░░░░░░░░░░░ ░░░░░░	░░░░░░░░░░░░░░ ░░░░░░	░░░░░░░░░░
░░░░░░░░ ░░░░░░ ░░░░░░░ ░░	░░░░░░░ ░░░░░░ ░░░░░░░░	░░░░░░░░░░
░░░░░░ ░░░░░░ ░░	░░░░░░░░░░░░░░ ░░░░░░	-
░░░░░░░ ░░░░░ ░░░░░ ░░░░ ░░░░ ░░░░░	░░░░░░░░░ ░░░░░░░░░░░░░░░░░	-

See the detail of Stig Anders Lindberg's experience

Training of Stig Anders Lindberg

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Stig Anders Lindberg's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	31
Merrill Lynch & Co., Inc. /Old/ Merrill Lynch & Co., Inc. /Old/ Investment Banks/BrokersFinance Provides wealth management, securities trading and sales, corporate finance and investment banking services	Finance
Cellectricon AB Cellectricon AB Miscellaneous Commercial ServicesCommercial Services Provides cell-based screening services to accelerate drug discovery	Commercial Services
Heartscape Technologies, Inc. Heartscape Technologies, Inc. Medical SpecialtiesHealth Technology Develops and markets cardiology devices	Health Technology
Affibody AB Affibody AB BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that develops radioligand therapies for cancer treatment	Health Technology
McKinsey & Co., Inc. McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a management consulting firm	Commercial Services
Affibody Medical AB Affibody Medical AB Pharmaceuticals: MajorHealth Technology Provides biopharmaceuticals services	Health Technology
Investor Growth Capital AB Investor Growth Capital AB Investment ManagersFinance IGC is a long-term investor with a top-down investment approach. They describe their investment attitude as patient and flexible. They are active investment partners seeking management teams operating in markets displaying sustainable growth characteristics. IGC commits themselves to board representation working closely for strategic decisions, financial and human resource allocations, potential acquisitions analyses and sources of additional capital. Their investee firms gain access to IGC's worldwide network of industry experts, advisors, and local knowledge over several geographic markets. IGC Europe invests primarily in expansion-stage firms in the technology and life sciences sectors in Northern Europe. They have an investment horizon from three to seven years. They typically invest between USD $3 million and $30 million. They acquire minority interest. IGC Asia targets expansion-stage firms in IT, software, semiconductors and Internet/media within Asia. Their investments range from USD $8 to $15 million over an investment period of three to six years. IGC US concentrates on investments in unlisted firms in healthcare and either listed or unlisted firms in IT sectors in North America. Generally, they invest in healthcare firms that have approved or marketed products. IT investments will typically be beyond the concept stage.	Finance
Karolinska Institutet Karolinska Institutet Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Alligator Bioscience AB Alligator Bioscience AB BiotechnologyHealth Technology Operates as a clinical stage biotechnology company that develops antibodies for the treatment of cancers	Health Technology
Newron Pharmaceuticals SpA Newron Pharmaceuticals SpA Pharmaceuticals: MajorHealth Technology Develops and sells novel therapies central & peripheral nervous system	Health Technology
SciBase Holding AB SciBase Holding AB Medical SpecialtiesHealth Technology Develops point of care device for the detection of malignant melanoma	Health Technology
Amic AB Amic AB Medical SpecialtiesHealth Technology Develops in vitro diagnostic technologies for use in point-of-care diagnostic tests	Health Technology
Newron Sweden AB Newron Sweden AB Pharmaceuticals: MajorHealth Technology Develops and manufactures therapeutic drugs for central nervous system disorders	Health Technology
University of Stockholm University of Stockholm Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Oncopeptides AB Oncopeptides AB Pharmaceuticals: MajorHealth Technology Develops chemotherapeutic pharmaceuticals of compounds for cancer treatment	Health Technology
Camurus AB Camurus AB Pharmaceuticals: MajorHealth Technology Provides nanoscale drug delivery systems for development of high value therapeutics	Health Technology
Atlas Antibodies AB Atlas Antibodies AB BiotechnologyHealth Technology Develops, produces and markets reagents for biomedical research	Health Technology
Dipylon Medical AB Dipylon Medical AB Pharmaceuticals: MajorHealth Technology Engages in the research and development of pharmaceutical products and manufactures medical instruments	Health Technology
Vårdapoteket i Norden AB Vårdapoteket i Norden AB Drugstore ChainsRetail Trade Owns and operates pharmacies	Retail Trade
Scibase Intressenter AB
Fiomi Diagnostics AB Fiomi Diagnostics AB Medical SpecialtiesHealth Technology Develops, manufactures and markets diagnostic test kits	Health Technology
Eirus Medical AB Eirus Medical AB Miscellaneous Commercial ServicesCommercial Services Provides medical technology development services	Commercial Services
Atlas Therapeutics AB Atlas Therapeutics AB Pharmaceuticals: MajorHealth Technology Develops and manufactures antibodies drugs	Health Technology
Ginolis AB Ginolis AB Miscellaneous ManufacturingProducer Manufacturing Develops components in polymer	Producer Manufacturing
Scibase AB
Lindberg Life-Science AB
Bostadsrattsforeningen Astraea
Kihlstroms Frimarkshandel AB
Bostadsrattsforeningen Johannes Mindre
Oncopeptides Incentive AB
Oncopeptides, Inc. Oncopeptides, Inc. Medical/Nursing ServicesHealth Services Develops therapies for hematological diseases	Health Services